Laboratory Analytical Instruments Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Laboratory Analytical Instruments
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-08-14 | COHR | Coherent Inc | Sobey Mark Stewart | EVP | S - Sale | $181.86 | -13,000 | 5,387 | -71% | -$2,364,170 | ||||||
| D | 2018-08-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $331.39 | -10,000 | 70,805 | -12% | -$3,313,861 | |||||
| D | 2018-08-09 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $585.00 | -500 | 41,761 | -1% | -$292,500 | |||||
2018-08-08 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.76 | +21 | 12,922,661 | 0% | +$142 | ||||||
| DM | 2018-08-07 | HBIO | Harvard Bioscience Inc | Duchemin Jeffrey | CEO | S - Sale+OE | $6.18 | -150,000 | 790,742 | -16% | -$927,170 | |||||
| D | 2018-08-07 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $6.08 | -100,015 | 349,286 | -22% | -$608,091 | |||||
| D | 2018-08-08 | PKI | Perkinelmer Inc | Sullivan Patrick J | Dir | S - Sale+OE | $86.19 | -12,672 | 38,752 | -25% | -$1,092,263 | |||||
| DM | 2018-08-07 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $587.67 | -1,500 | 41,761 | -3% | -$881,500 | |||||
2018-08-06 | PKI | Perkinelmer Inc | Lopardo Nicholas A | Dir | S - Sale | $85.60 | -3,505 | 53,347 | -6% | -$300,028 | ||||||
| DM | 2018-08-03 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $590.07 | -3,000 | 41,761 | -7% | -$1,770,200 | |||||
2018-08-02 | ILMN | Illumina Inc | Ostadan Omead | EVP Ops, Products, Strategy | S - Sale | $320.70 | -1,334 | 24,484 | -5% | -$427,814 | ||||||
2018-08-02 | ILMN | Illumina Inc | Stapley Marc | EVP Strategy, Corp Developmt | S - Sale | $324.80 | -1,000 | 25,425 | -4% | -$324,798 | ||||||
2018-08-02 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.36 | +29 | 13,202,853 | 0% | +$184 | ||||||
| D | 2018-08-02 | PKI | Perkinelmer Inc | Okun Andrew | Please See Remarks | S - Sale+OE | $82.18 | -14,045 | 8,884 | -61% | -$1,154,218 | |||||
| D | 2018-08-02 | PKI | Perkinelmer Inc | Goldberg Joel S | Please See Remarks | S - Sale+OE | $85.00 | -34,608 | 62,311 | -36% | -$2,941,680 | |||||
| DM | 2018-08-01 | PKI | Perkinelmer Inc | Friel Robert F | Pres, CEO | S - Sale+OE | $81.60 | -218,579 | 572,657 | -28% | -$17,836,032 | |||||
2018-08-01 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $327.41 | -2,100 | 76,535 | -3% | -$687,555 | ||||||
2018-07-31 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.40 | +2,692 | 13,202,824 | 0% | +$17,230 | ||||||
| D | 2018-07-27 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.54 | -62,514 | 361,801 | -15% | -$346,328 | |||||
2018-07-27 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.14 | +20,029 | 13,200,132 | 0% | +$123,071 | ||||||
2018-07-24 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale | $5.25 | -5,570 | 374,315 | -1% | -$29,243 | ||||||
| DM | 2018-07-23 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $63.54 | -69,871 | 2,027,619 | -3% | -$4,439,758 | |||||
2018-07-23 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale | $311.15 | -500 | 6,139 | -8% | -$155,575 | ||||||
| M | 2018-07-19 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale | $5.25 | -2,565 | 379,885 | -1% | -$13,466 | |||||
| D | 2018-07-17 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $63.50 | -31,353 | 2,027,619 | -2% | -$1,990,981 | |||||
| DM | 2018-07-12 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.25 | -10,207 | 382,450 | -3% | -$53,587 | |||||
2018-07-12 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.27 | +54 | 13,180,049 | 0% | +$339 | ||||||
| D | 2018-07-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $288.89 | -7,500 | 70,996 | -10% | -$2,166,701 | |||||
| DM | 2018-07-09 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.26 | -169,200 | 386,829 | -30% | -$889,527 | |||||
| M | 2018-07-09 | HBIO | Harvard Bioscience Inc | Duchemin Jeffrey | CEO | S - Sale | $5.33 | -40,000 | 790,742 | -5% | -$213,353 | |||||
| DM | 2018-07-09 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $64.01 | -159,752 | 2,027,619 | -7% | -$10,225,409 | |||||
| M | 2018-06-22 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.80 | +95 | 13,180,049 | 0% | +$551 | |||||
| D | 2018-06-25 | EYPT | Eyepoint Pharmaceuticals, Inc. | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.26 | +16,864,066 | 50,940,780 | +49% | +$21,333,043 | |||||
2018-07-02 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $276.14 | -2,100 | 82,271 | -2% | -$579,887 | ||||||
2018-06-21 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale | $288.45 | -500 | 6,639 | -7% | -$144,225 | ||||||
2018-06-19 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.72 | +10,593 | 13,179,954 | 0% | +$49,960 | ||||||
| M | 2018-06-15 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.80 | +121,549 | 13,169,361 | +1% | +$583,984 | |||||
2018-06-15 | IART | Integra Lifesciences Holdings Corp | Reuvers Daniel L. | CVP,PRES - CODMAN SPC SURGICAL | S - Sale | $66.97 | -1,000 | 25,009 | -4% | -$66,970 | ||||||
| M | 2018-06-12 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.95 | +149,715 | 13,047,812 | +1% | +$741,242 | |||||
2018-06-13 | BIO | Bio Rad Laboratories Inc | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $303.42 | -350 | 2,142 | -14% | -$106,197 | ||||||
2018-06-11 | ILMN | Illumina Inc | Stapley Marc | EVP Strategy, Corp Developmt | S - Sale | $285.18 | -1,446 | 26,425 | -5% | -$412,364 | ||||||
| D | 2018-06-11 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $284.83 | -10,500 | 70,996 | -13% | -$2,990,759 | |||||
| D | 2018-06-11 | A | Agilent Technologies Inc | Fields Heidi | Dir | S - Sale+OE | $66.47 | -5,000 | 65,170 | -7% | -$332,375 | |||||
| D | 2018-06-12 | A | Agilent Technologies Inc | Koh Boon Hwee | Dir | S - Sale+OE | $66.38 | -6,931 | 83,643 | -8% | -$460,099 | |||||
| M | 2018-06-07 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.52 | +55,763 | 12,898,097 | 0% | +$307,627 | |||||
| D | 2018-06-07 | MTD | Mettler Toledo International Inc/ | Heidingsfelder Michael | Head of Industrial | S - Sale+OE | $590.00 | -2,562 | 0 | -100% | -$1,511,580 | |||||
| D | 2018-06-08 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $595.00 | -700 | 2,778 | -20% | -$416,500 | |||||
| DM | 2018-06-06 | MTD | Mettler Toledo International Inc/ | Spoerry Robert F | Dir | S - Sale+OE | $582.80 | -5,355 | 362,413 | -1% | -$3,120,900 | |||||
| DM | 2018-06-06 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $587.83 | -1,150 | 2,778 | -29% | -$676,000 | |||||
| D | 2018-06-05 | QTRX | Quanterix Corp | Orticerio Ernest | SVP Finance, Corporate Dev | S - Sale+OE | $17.15 | -25,000 | 53,802 | -32% | -$428,633 | |||||
2018-06-01 | ILMN | Illumina Inc | Ostadan Omead | EVP Ops, Products, Strategy | S - Sale | $274.61 | -1,335 | 25,818 | -5% | -$366,604 | ||||||
2018-06-01 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $272.91 | -2,100 | 84,371 | -2% | -$573,107 | ||||||
| D | 2018-06-01 | WAT | Waters Corp /de/ | Harrington Michael C | SVP, Global Markets | S - Sale+OE | $194.64 | -15,000 | 2,037 | -88% | -$2,919,600 | |||||
2018-05-29 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.59 | +1,200 | 12,723,132 | 0% | +$6,714 | ||||||
2018-05-25 | PKI | Perkinelmer Inc | Lopardo Nicholas A | Dir | S - Sale | $74.92 | -4,000 | 56,852 | -7% | -$299,680 | ||||||
| M | 2018-05-24 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.69 | +9,970 | 12,721,932 | 0% | +$56,693 | |||||
2018-05-22 | WAT | Waters Corp /de/ | Reed Joann A | Dir | S - Sale | $195.77 | -2,090 | 17,932 | -10% | -$409,155 | ||||||
2018-05-21 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale | $271.00 | -500 | 6,588 | -7% | -$135,500 | ||||||
2018-05-21 | ILMN | Illumina Inc | Eastham Karin | Dir | S - Sale | $269.80 | -1,000 | 12,288 | -8% | -$269,802 | ||||||
| DM | 2018-05-17 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $564.73 | -3,372 | 41,761 | -7% | -$1,904,258 | |||||
| DM | 2018-05-17 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $566.95 | -2,850 | 2,778 | -51% | -$1,615,800 | |||||
| D | 2018-05-16 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $267.71 | -10,000 | 70,996 | -12% | -$2,677,135 | |||||
| D | 2018-05-17 | WAT | Waters Corp /de/ | Silveira Michael F | VP, Corporate Controller | S - Sale+OE | $190.77 | -3,521 | 949 | -79% | -$671,716 | |||||
2018-05-15 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | P - Purchase | $20.00 | +10,000 | 14,718,738 | 0% | +$200,000 | ||||||
2018-05-14 | ILMN | Illumina Inc | Flatley Jay T | Dir | S - Sale | $268.00 | -1,460 | 399,504 | 0% | -$391,280 | ||||||
2018-05-14 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $268.63 | -2,100 | 86,471 | -2% | -$564,124 | ||||||
2018-05-14 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | P - Purchase | $19.97 | +65,000 | 14,708,738 | 0% | +$1,298,050 | ||||||
| D | 2018-05-14 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $567.86 | -4,000 | 41,761 | -9% | -$2,271,420 | |||||
2018-05-11 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | P - Purchase | $19.33 | +100,000 | 14,643,738 | +1% | +$1,932,762 | ||||||
| DM | 2018-05-10 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $563.38 | -5,000 | 41,761 | -11% | -$2,816,895 | |||||
2018-05-09 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.37 | +16,900 | 12,711,962 | 0% | +$90,836 | ||||||
| M | 2018-05-07 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.54 | +77,700 | 12,695,062 | +1% | +$430,594 | |||||
| M | 2018-05-01 | ARYC | Arrayit Corp | Nielsen Jason | 10% | P - Purchase | $0.01 | +6,639,500 | 142,816,345 | +5% | +$70,663 | |||||
| D | 2018-05-07 | WAT | Waters Corp /de/ | Harrington Michael C | SVP, Global Markets | S - Sale+OE | $194.67 | -16,078 | 2,037 | -89% | -$3,129,849 | |||||
| M | 2018-05-03 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.69 | +92,205 | 12,617,362 | +1% | +$524,551 | |||||
2018-05-02 | ILMN | Illumina Inc | Ostadan Omead | EVP Ops, Products, Strategy | S - Sale | $242.60 | -1,314 | 27,153 | -5% | -$318,776 | ||||||
| D | 2018-05-01 | ILMN | Illumina Inc | Bowman A Blaine | Dir | S - Sale+OE | $241.44 | -3,000 | 17,736 | -14% | -$724,336 | |||||
2018-04-30 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.92 | +6,649 | 12,525,157 | 0% | +$39,370 | ||||||
2018-04-30 | IART | Integra Lifesciences Holdings Corp | Reuvers Daniel L. | CVP,PRES - CODMAN SPC SURGICAL | S - Sale | $62.04 | -1,000 | 26,009 | -4% | -$62,045 | ||||||
2018-04-26 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.96 | +9,609 | 12,518,508 | 0% | +$57,271 | ||||||
| M | 2018-04-24 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.93 | +3,700 | 12,508,899 | 0% | +$21,939 | |||||
| M | 2018-04-19 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.92 | +10,513 | 12,505,199 | 0% | +$62,272 | |||||
2018-04-18 | PKI | Perkinelmer Inc | Tereau Daniel R | Please See Remarks | S - Sale | $77.00 | -1,156 | 6,784 | -15% | -$89,012 | ||||||
2018-04-12 | ILMN | Illumina Inc | Van Oene Mark | SVP Chief Commercial Officer | S - Sale | $238.48 | -1,400 | 12,217 | -10% | -$333,872 | ||||||
2018-04-03 | ILMN | Illumina Inc | Dadswell Charles | SVP, GC | S - Sale | $230.91 | -116 | 7,875 | -1% | -$26,786 | ||||||
| D | 2018-04-02 | ILMN | Illumina Inc | Bowman A Blaine | Dir | S - Sale+OE | $230.13 | -3,000 | 17,736 | -14% | -$690,383 | |||||
2018-04-02 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.73 | +7,240 | 12,494,686 | 0% | +$41,496 | ||||||
2018-03-28 | PSDV | Eyepoint Pharmaceuticals, Inc. | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.10 | +8,606,324 | 17,212,648 | +100% | +$9,466,956 | ||||||
| D | 2018-03-29 | A | Agilent Technologies Inc | Kaltenbach Patrick | SVP | S - Sale+OE | $67.28 | -4,000 | 68,547 | -6% | -$269,113 | |||||
| D | 2018-03-27 | A | Agilent Technologies Inc | Fields Heidi | Dir | S - Sale+OE | $68.09 | -5,000 | 65,051 | -7% | -$340,450 | |||||
| M | 2018-03-23 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.83 | +21,020 | 12,490,361 | 0% | +$122,465 | |||||
| D | 2018-03-14 | HBIO | Harvard Bioscience Inc | Uveges George | Dir | S - Sale+OE | $4.58 | -22,250 | 142,685 | -13% | -$101,905 | |||||
2018-03-15 | ILMN | Illumina Inc | Arnold Frances | Dir | S - Sale | $252.26 | -250 | 10,189 | -2% | -$63,065 | ||||||
| D | 2018-03-14 | IART | Integra Lifesciences Holdings Corp | Coleman Glenn | CVP, CFO | S - Sale+OE | $56.10 | -8,769 | 33,417 | -21% | -$491,967 | |||||
| D | 2018-03-13 | A | Agilent Technologies Inc | Gonsalves Rodney | VP, Corporate Controller | S - Sale+OE | $71.23 | -6,825 | 24,425 | -22% | -$486,145 | |||||
2018-03-13 | A | Agilent Technologies Inc | Doak Mark | SVP | S - Sale | $71.00 | -2,441 | 65,533 | -4% | -$173,311 | ||||||
| D | 2018-03-12 | A | Agilent Technologies Inc | Kaltenbach Patrick | SVP | S - Sale+OE | $71.38 | -6,875 | 68,547 | -9% | -$490,738 | |||||
| M | 2018-03-08 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.48 | +40,107 | 12,469,341 | 0% | +$259,825 | |||||
2018-03-07 | HBIO | Harvard Bioscience Inc | Uveges George | Dir | S - Sale | $4.61 | -35,054 | 163,028 | -18% | -$161,599 | ||||||
| M | 2018-03-08 | HBIO | Harvard Bioscience Inc | Duchemin Jeffrey | CEO | S - Sale | $4.53 | -87,022 | 641,854 | -12% | -$393,963 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |